glp-1 and glp-2 drugs medication its types glp 1 equivalency chart Promising

GLP1 receptor agonistseffects beyond obesity and diabetes

Our results are generally consistent in direction and magnitude with the existing clinical research, including trials showing reduced heavy alcohol consumption among those with obesity,14 reduced drinking in an experimental bar setting,12 and pharmacoepidemiological analyses showing that GLP-1 receptor agonists are associated with lower incidence and recurrence of alcohol use disorder,2 reduced need for tobacco use related care,5 lower incidence and relapse of cannabis use disorder,4 and reduced risk of opioid overdose in patients with opioid use disorders.8 Our results show that among people with a pre-existing SUD, GLP-1 receptor agonist use was associated with a reduced risk of several adverse clinical outcomes (SUD related emergency department visits, hospital admission, and mortality, drug overdose, and suicidal attempt or ideation)

Refunds required by applicable law

That's a lot of people at an increased risk of health complications

10.2147/PPA.S82866

Because of these effects, GLP-1 has gained popularity in managing blood sugar and weight